Search research articles
Contact Us
Filters
Showing results (221-230 of 419) with videos related to
Page
of 42
Sort By:
Frontiers in Chemistry
|
November 11, 2020
Sensitive LC-MS/MS Method for the Quantification of Macrocyclic Gα<sub>q</sub> Protein Inhibitors in Biological Samples
Markus Kuschak, Jonathan G Schlegel, Marion Schneider, et al.
Molecular and Cellular Biology
|
July 22, 1998
Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene
J Soret, R Gattoni, C Guyon, et al.
The Lancet. Oncology
|
November 13, 2018
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Martin H Voss, Albert Reising, Yuan Cheng, et al.
Clinical Genitourinary Cancer
|
September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
Chung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Communications Chemistry
|
June 1, 2023
Crystal structure of adenosine A<sub>2A</sub> receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction
Tobias Claff, Jonathan G Schlegel, Jan H Voss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2014
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
M H Voss, D A Bastos, C A Karlo, et al.
Clinical Genitourinary Cancer
|
February 13, 2021
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic
Michal Sarfaty, Darren R Feldman, Michael J Morris, et al.
International Journal of Molecular Sciences
|
March 4, 2016
Dietary Apigenin Exerts Immune-Regulatory Activity in Vivo by Reducing NF-κB Activity, Halting Leukocyte Infiltration and Restoring Normal Metabolic Function
Horacio Cardenas, Daniel Arango, Courtney Nicholas, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?
Jonathan G Schlegel, Mariam Tahoun, Alexander Seidinger, et al.
The Oncologist
|
June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
Maria I Carlo, Ana M Molina, Yulia Lakhman, et al.
Page
of 42
Search research articles
Search
Showing results (221-230 of 419) with videos related to
Sort By:
Page
of 42
Frontiers in Chemistry
|
November 11, 2020
Sensitive LC-MS/MS Method for the Quantification of Macrocyclic Gα<sub>q</sub> Protein Inhibitors in Biological Samples
Markus Kuschak, Jonathan G Schlegel, Marion Schneider, et al.
Molecular and Cellular Biology
|
July 22, 1998
Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene
J Soret, R Gattoni, C Guyon, et al.
The Lancet. Oncology
|
November 13, 2018
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study
Martin H Voss, Albert Reising, Yuan Cheng, et al.
Clinical Genitourinary Cancer
|
September 26, 2015
Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs
Chung-Han Lee, Andreas M Hötker, Martin H Voss, et al.
Communications Chemistry
|
June 1, 2023
Crystal structure of adenosine A<sub>2A</sub> receptor in complex with clinical candidate Etrumadenant reveals unprecedented antagonist interaction
Tobias Claff, Jonathan G Schlegel, Jan H Voss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2014
Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies
M H Voss, D A Bastos, C A Karlo, et al.
Clinical Genitourinary Cancer
|
February 13, 2021
Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic
Michal Sarfaty, Darren R Feldman, Michael J Morris, et al.
International Journal of Molecular Sciences
|
March 4, 2016
Dietary Apigenin Exerts Immune-Regulatory Activity in Vivo by Reducing NF-κB Activity, Halting Leukocyte Infiltration and Restoring Normal Metabolic Function
Horacio Cardenas, Daniel Arango, Courtney Nicholas, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Macrocyclic Gq Protein Inhibitors FR900359 and/or YM-254890-Fit for Translation?
Jonathan G Schlegel, Mariam Tahoun, Alexander Seidinger, et al.
The Oncologist
|
June 12, 2016
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
Maria I Carlo, Ana M Molina, Yulia Lakhman, et al.
Page
of 42